In the Yang study, they proved that IGFBP-6 may have profound effects on the migration of two ovarian cancer cell lines, which may help in developing an IGFBP-6-based therapeutic for ovarian cancers (30). This evidence concerns the gene IGFBP6 and ovarian cancer.